Medical Journals

Compensatory Alteration of Inhibitory Synaptic Circuits in Cerebellum and Thalamus of Gamma-aminobutyric Acid Type A Receptor Alpha1 Subunit Knockout Mice.

Authors:
  • Kralic Jason E
  • Sidler Corinne
  • Parpan Franziska
  • Homanics Gregg E
  • Morrow A Leslie
  • Fritschy Jean-Marc

From: Institute of Pharmacology and Toxicology, University of Zurich, CH-8057 Zurich, Switzerland.

The Journal of comparative neurology

  • Publish Date: Apr 2006
  • ISSN: 0021-9967
  • Volume: 495
  • Issue: 4
  • Pages: 408-21
  • Medium: Print
  • Language: English
  • Citation (JAMA): Kralic Jason E, Sidler Corinne, Parpan Franziska, et al. Compensatory Alteration of Inhibitory Synaptic Circuits in Cerebellum and Thalamus of Gamma-aminobutyric Acid Type A Receptor Alpha1 Subunit Knockout Mice.. J. Comp. Neurol. Apr 2006;495:408-21

Abstract

Targeted deletion of the alpha1 subunit gene results in a profound loss of gamma-aminobutyric acid type A (GABA(A)) receptors in adult mouse brain but has only moderate behavioral consequences. Mutant mice exhibit several adaptations in GABA(A) receptor subunit expression, as measured by Western blotting. By using immunohistochemistry, we investigated here whether these adaptations serve to replace the missing alpha1 subunit or represent compensatory changes in neurons that normally express these subunits. We focused on cerebellum and thalamus and distinguished postsynaptic GABA(A) receptor clusters by their colocalization with gephyrin. In the molecular layer of the cerebellum, alpha1 subunit clusters colocalized with gephyrin disappeared from Purkinje cell dendrites of mutant mice, whereas alpha3 subunit/gephyrin clusters, presumably located on dendrites of Golgi interneurons, increased sevenfold, suggesting profound network reorganization in the absence of the alpha1 subunit. In thalamus, a prominent increase in alpha3 and alpha4 subunit immunoreactivity was evident, but without change in regional distribution. In the ventrobasal complex, which contains primarily postsynaptic alpha1- and extrasynaptic alpha4-GABA(A) receptors, the loss of alpha1 subunit was accompanied by disruption of gamma2 subunit and gephyrin clustering, in spite of the increased alpha4 subunit expression. However, in the reticular nucleus, which lacks alpha1-GABA(A) receptors in wild-type mice, postsynaptic alpha3/gamma2/gephyrin clusters were unaffected. These results demonstrate that adaptive responses in the brain of alpha1(0/0) mice involve reorganization of GABAergic circuits and not merely replacement of the missing alpha1 subunit by another receptor subtype. In addition, clustering of gephyrin at synaptic sites in cerebellum and thalamus appears to be dependent on expression of a GABA(A) receptor subtype localized postsynaptically.

Mesh Headings (Keywords): Animals, Blotting, Western, Brain, Carrier Proteins, Cerebellum, Immunohistochemistry, Membrane Proteins, Mice, Mice, Knockout, Neural Inhibition, Receptors, GABA-A, Synapses, Thalamus


Check for Full Text / PubMed Unique Identifier (PMID): 16485284


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.